Beta
Company data is growing.
← All companies
/
Top lists
/
Amgen
Amgen
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
22 991
22 849
23 747
23 362
25 424
25 979
26 323
28 190
33 424
36 751
Operating profit (EBIT)
9 794
9 973
10 263
9 674
9 139
7 639
9 566
7 897
7 258
9 080
Net income attributable to shareholders
7 722
1 979
8 394
7 842
7 264
5 893
6 552
6 717
4 090
7 711
EBIT margin
42,6%
43,7%
43,2%
41,4%
36,0%
29,4%
36,3%
28,0%
21,7%
24,7%
Gross margin
81,9%
82,2%
82,7%
81,4%
75,8%
75,2%
75,7%
70,0%
61,5%
67,3%
Operating cash flow
10 354
11 177
11 296
9 150
10 497
9 261
9 721
8 471
11 490
9 958
Free cash flow
9 616
10 513
10 558
8 532
9 889
8 381
8 785
7 359
10 394
8 100
Cash
3 241
3 800
6 945
6 037
6 266
7 989
7 629
10 944
11 973
9 129
0
10 000
20 000
30 000
40 000
0,0%
20,0%
40,0%
60,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
22 991
22 849
23 747
23 362
25 424
25 979
26 323
28 190
33 424
36 751
9 794
9 973
10 263
9 674
9 139
7 639
9 566
7 897
7 258
9 080